BusinessEarth Science Tech, Inc. Partners with Centre SIDA Amite Clinic to Commence Final Pre-Launch MSN-2 Human Research StudyBy Nasdaq OMXOct 10, 2017, 12:31 PM UTC
BusinessEarth Science Tech, Inc. Announces New Agreement with Axcelon Biopolymers Corp. for Distribution of Nanoderm™ Medical Device & Advances with Its MSN-2 Medical DeviceBy Nasdaq OMXSep 19, 2017, 12:45 PM UTC
BusinessEarth Science Tech, Inc. Signs Contract with Absolu to Advance Phase-2 Rollout on MSN-2 Medical DeviceBy Nasdaq OMXAug 3, 2017, 12:35 PM UTC
BusinessEarth Science Tech, Inc. Launches Earth Science Pharmaceutical & MSN-2 Medical Device Websites, Adds Michel Gauthier M.D. to the Advisory Board, and Reports Over 80% Profit IncreaseBy Nasdaq OMXJun 19, 2017, 12:15 PM UTC
BusinessEarth Science Tech, Inc. Announces Timeline Projection for its MSN-2 Medical Device, and Partnership Negotiations for its Cannabis CBD-Based Generic Drugs & Medical Device DistributionBy Nasdaq OMXMar 27, 2017, 4:12 PM UTC
BusinessETST Announces Recruitment of Key Individuals for its Two Subsidiaries and the Leasing of a Manufacturing Facility to Produce its MSN-2 Medical Device.By Nasdaq OMXMar 14, 2017, 12:01 PM UTC
BusinessETST Announces Recruitment of Key Individuals for its Two Subsidiaries and the Leasing of a Manufacturing Facility to Produce its MSN-2 Medical Device.By Nasdaq OMXMar 14, 2017, 12:01 PM UTC
